LEUKEMIA 360 is a professional event that is not open to the general public. Participants include representatives from industry (pharmaceuticals, biotechnology, medical technologies, in vitro diagnostics, digital/AI), academia (key opinion leaders, researchers, and clinicians, including intrapreneurs), investors, research institutions, and patient associations active or interested in the field of leukemia and related diseases. Registration is mandatory and may be subject to validation by the organizers. Early registration is recommended, as capacity is limited to 300 pax. Various sponsorship opportunities are available upon request.